Global Flexible Endoscopy Equipment Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030
Flexible Endoscopy Equipment are medical instruments equipped with a flexible tube that contains a light source and a camera. They allow physicians to examine the inside of the body without the need for invasive surgery. These devices are commonly used in gastroenterology, urology, pulmonology, and other medical specialties. Flexible endoscopes are inserted through natural body openings or small incisions and provide real-time images of the internal organs, enabling accurate diagnosis and treatment.
Market Overview:The latest research study on the global Flexible Endoscopy Equipment market finds that the global Flexible Endoscopy Equipment market reached a value of USD 6522.48 million in 2023. It’s expected that the market will achieve USD 9342.72 million by 2029, exhibiting a CAGR of 6.17% during the forecast period.
Increased prevalence of gastrointestinal disease
The incidence of gastrointestinal diseases such as colorectal cancer, esophageal diseases and gastrointestinal ulcers has continued to rise, and the demand for accurate diagnosis and treatment of flexible endoscopy equipment has been promoted. In recent years, with the changes in lifestyle, living environment and the acceleration of population aging, inflammatory bowel disease (IBD), bowel cancer, gastric cancer and other gastrointestinal diseases have increased year by year, becoming common diseases in the new era. For instance, in 2024, the American Cancer Society estimated that there were about 106,590 new cases of colon cancer (54,210 in men and 52,380 in women) in the U.S., as well as 46,220 new cases of rectal cancer (27,330 in men and 18,890 in women). In addition, according to China's National Cancer Center, the current cancer structure of China is still mainly based on lung cancer, liver cancer, gastric cancer, colorectal cancer, and esophageal cancer. Among them, digestive tract tumors occupy three seats. The onset of the first five malignant tumors accounted for about 57.27%of all new cases. Lung cancer, liver cancer, gastric cancer, colorectal cancer, and esophageal cancer are the main cause of tumor death, accounting for about 69.25%of all tumor death cases. The increasing prevalence of gastrointestinal diseases and other diseases is promoting the use of flexible endoscopy equipment.
Region Overview:In 2022, the share of the Flexible Endoscopy Equipment market in United States stood at 43.70%.
Company Overview:Olympus Corporation is one of the major players operating in the Flexible Endoscopy Equipment market, holding a share of 49.35% in 2023.
Olympus is focused on improving the quality of patient care by developing and designing advanced precision technologies and services to achieve this goal. The medical specialties served by the company are otolaryngology, gastroenterology, general surgery, gynecology, neurosurgery, pulmonology and urology. Medical solutions include hygiene and reprocessing, OR integration, endoscopic therapy and transnasal endoscopy. The company's products enable healthcare professionals from a wide range of specialties to use endoscopic procedures to treat within the body, focusing on the early detection and minimally invasive treatment of a wide range of diseases.
Segmentation Overview:By type, Gastroscopes segment accounted for the largest share of market in 2022.
Application Overview:By application, the Hospitals segment occupied the biggest share from 2018 to 2022.
Key Companies in the global Flexible Endoscopy Equipment market covered in Chapter 3:Richard Wolf GmbH
Olympus Corporation
FUJIFILM Medical Systems
KARL STORZ
HOYA
SonoScape
Boston Scientific
AOHUA
In Chapter 4 and Chapter 14.2, on the basis of types, the Flexible Endoscopy Equipment market from 2019 to 2030 is primarily split into:Colonoscopes
Gastroscopes
Bronchoscopes
Others
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Flexible Endoscopy Equipment market from 2019 to 2030 covers:Hospitals
Ambulatory Surgical Centers/Clinics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)